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365 Potentiation of paclitaxel cytotoxicity in lung and esophageal cancer cells by
pharmacologic inhibition of the phosphoinositide 3-kinase/protein kinase
B (Akt)–mediated signaling pathway
Dao M. Nguyen, MD, MSc, FRCSC, FACS, G. Aaron Chen, MS, Rishindra Reddy, MD,
Wilson Tsai, MD, William D. Schrump, George Cole, Jr, MD, and
David S. Schrump, MD, FACS, Bethesda, Md
Pharmacologic inhibition of the PI3K/Akt-mediated cell survival signal transduction pathway in
cultured lung or esophageal cancer cells enhances their sensitivity to the cytotoxic effect of
paclitaxel. Inhibition of PI3K/Akt suppresses NF-B transcription activity and down-regulates
NF-B–dependent expression of antiapoptotic proteins. These findings may provide the
molecular basis for the chemosensitization effect of PI3K/Akt inhibition.
376 Endotracheal calcineurin inhibition ameliorates injury in an experimental
model of lung ischemia-reperfusion
Steven M. Woolley, MRCS, Alexander S. Farivar, MD, Babu V. Naidu, FRCS,
Matthew Rosengart, MD, Robert Thomas, BA, Charles Fraga, MS, and
Michael S. Mulligan, MD, FACS, Seattle, Wash
Endotracheal tacrolimus is protective against lung ischemia-reperfusion injury in an
experimental model and decreases both proinflammatory nuclear transcription factor activation
and chemokine and cytokine expression.
Surgery for Acquired
Cardiovascular Disease
(ACD)
385 Why do patients with ischemic cardiomyopathy and a substantial amount of
viable myocardium not always recover in function after revascularization?
Arend F. L. Schinkel, MD, Don Poldermans, MD, Vittoria Rizzello, MD,
Jean-Louis J. Vanoverschelde, MD, Abdou Elhendy, MD, Eric Boersma, PhD,
Jos R. T. C. Roelandt, MD, and Jeroen J. Bax, MD, Rotterdam, The Netherlands,
Brussels, Belgium, and Leiden, The Netherlands
In 118 consecutive patients with ischemic cardiomyopathy, not only the amount of
dysfunctional but viable myocardium but also the extent of left ventricular remodeling
determined the improvement in function following myocardial revascularization. Patients with a
high end systolic volume due to remodeling have a decreased likelihood of improvement of
global function.
391 Aortic root surgery in Marfan syndrome: Comparison of aortic valve-
sparing reimplantation versus composite grafting
Matthias Karck, MD, Klaus Kallenbach, MD, Christian Hagl, MD, Christine Rhein, MD,
Rainer Leyh, MD, and Axel Haverich, MD, Hannover, Germany
The midterm results of aortic root replacement and aortic valve reimplantation according to
David are similar in patients with Marfan syndrome. We favor the latter technique for these
patients because long-term anticoagulation is not required.
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